𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon/antioxidant combination therapy for chronic hepatitis C—a controlled pilot trial

✍ Scribed by Markus P Look; Alexandra Gerard; Govind S Rao; Thomas Sudhop; Hans-Peter Fischer; Tilman Sauerbruch; Ulrich Spengler

Book ID
114145239
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
128 KB
Volume
43
Category
Article
ISSN
0166-3542

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-α and zidovudine combination
Interferon-α and zidovudine combination therapy for chronic hepatitis B: Results of a randomized, placebo-controlled trial
✍ Harry L. A. Janssen; Luuk Berk; Rudolf A. Heijtink; Fiebo J. W. Ten Kate; Solko 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

Interferon-a therapy leads to HBeAg seroconversion in only one third of patients with chronic hepatitis B. In an attempt to increase the seroconversion rate, we investigated the combination of interferon-a and zidovudine in a subset of patients with presumably low response rates for interferon-a mon

A randomized controlled trial of high-do
A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C
✍ Di Marco, Vito; Lo Iacono, Oreste; Cammà, Calogero; Almasio, Piero L.; Vaccaro, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

In chronic hepatitis C virus (HCV) infection, the rate of sustained response to interferon is low. We evaluated, in patients responding to a 26-week course of interferon, the effect of high-dose maintenance therapy in preventing relapse. Three hundred and ten patients with chronic HCV infection (38.